This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 4460783 results found since Jan 2013.
Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space.
Conclusions: CT-guided HDR interstitial brachytherapy is a safe and feasible method for local ablation of oligometastatic lymph node metastases of the retroperitoneal space, and might provide a well-tolerated additional therapeutic option in the multidisciplinary management of selected patients.
PMID: 31749852 [PubMed]
Source: Journal of Contemporary Brachytherapy - November 22, 2019 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Endovascular brachytherapy for extensive right-heart and pulmonary artery sarcoma - a case report.
Conclusions: Endovascular brachytherapy is a novel, safe and effective therapeutic modality for non-resectable primary cardiac sarcomas either for palliation of obstruction, or tumor mass reduction to allow complete resection.
PMID: 31969917 [PubMed]
Source: Journal of Contemporary Brachytherapy - January 25, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
A dosimetric study of electron beam therapy vs. high-dose-rate mould brachytherapy in adjuvant treatment of non-melanoma skin carcinomas of the head and neck region.
Conclusions: CT-based surface mould brachytherapy results in better conformity of superficial lesions on small, irregular surfaces such as the nose and inner canthus than electrons with a slightly higher skin dose.
PMID: 31969913 [PubMed]
Source: Journal of Contemporary Brachytherapy - January 25, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand.
Conclusions: The first interstitial and surface HDR brachytherapy for cutaneous squamous cell carcinoma of a finger interspace for hand function preservation is presented. The initial experience revealed that brachytherapy was tolerated but with notable acute and late side effects. Treatment did result in tumor shrinkage with organ preservation and function of two rays. A larger cohort of patients will be required for additional conclusions related to long-term clinical benefits in patients who refuse ray amputation.
PMID: 32190070 [PubMed]
Source: Journal of Contemporary Brachytherapy - March 21, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
3D printer-based novel intensity-modulated vaginal brachytherapy applicator: feasibility study.
Conclusions: The novel brachytherapy applicator met the necessary requirements in quality control tests.
PMID: 32190066 [PubMed]
Source: Journal of Contemporary Brachytherapy - March 21, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer.
Conclusions: Larger rectal volumes are associated with higher rectal dose parameters during HDR brachytherapy using inverse planning optimization. This method spares OAR, while producing reasonable HR-CTV D90. Prospective studies are needed to find appropriate technique of rectal volume reduction.
PMID: 32395146 [PubMed]
Source: Journal of Contemporary Brachytherapy - May 14, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Comparison of initial computed tomography-based target delineation and subsequent magnetic resonance imaging-based target delineation for cervical cancer brachytherapy.
Conclusions: The use of asynchronous MRI for target delineation, with co-registration to CT for each fraction of brachytherapy was associated with higher D90 to the HR-CTV. We observed slightly higher D2cc rectal doses with MRI, but cumulative rectal doses were within accepted thresholds. High-risk target volumes were not consistently increased or decreased, but MRI fusion was associated with target volume changes greater than 20% in over half of the treated patients.
PMID: 32695201 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 24, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy.
Conclusions: Our palliative treatment technique appears to be safe, effective, and less invasive, and could be a treatment option for symptomatic patients with head and neck cancer.
PMID: 32695200 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 24, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Brachytherapy practice during the COVID-19 pandemic: a review on the practice changes.
Authors: Barthwal M, Pareek V, Mallick S, Sharma DN
Abstract
The COVID-19 pandemic has caused a havoc across the globe, and has significantly affected oncology services, especially radiation therapy due to the need of social distancing as a measure for the pandemic mitigation. Brachytherapy, being an integral part of radiation therapy, posts a dilemma related to the practice of evidence-based oncology. It requires a significant amount of resources and personnel, thereby increasing the risk of exposure to the virus. There has been a significant amount of papers published providing the best available alternatives to ...
Source: Journal of Contemporary Brachytherapy - December 10, 2020 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Perineal recurrence of prostate ductal adenocarcinoma after transperineal brachytherapy: a case report and literature review.
Authors: Fukagai T, Hirayama K, Morita M, Nishimura K, Yamatoya J, Noguchi T, Ogawa Y, Igarashi A, Morota M, Kato M, Oshinomi K, Ogawa Y, Tsuzuki T
Abstract
Perineal recurrence after brachytherapy is an exceedingly rare complication. Moreover, ductal adenocarcinoma is a rare histological variant of prostate cancer. Herein, we describe a case of perineal recurrence from ductal adenocarcinoma of prostate after low-dose-rate brachytherapy (LDR-BT) in a 65-year-old male patient. The patient had localized prostate cancer, for which he received LDR-BT; however, he experienced perineal recurrence 2 years after receiving L...
Source: Journal of Contemporary Brachytherapy - January 15, 2021 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer.
Conclusions: Focal LDR prostate brachytherapy appears acceptable for MRI-based index tumors, with a low cumulative incidence of BCR. Such brachytherapy might offer a feasible minimally invasive therapeutic option for localized prostate cancer.
PMID: 33437303 [PubMed]
Source: Journal of Contemporary Brachytherapy - January 15, 2021 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Examining the evidence in pursuit of the highest possible brachytherapy standards
“Not every thing that counts can be counted; Not everything that can be counted counts”—Albert Einstein Since 1993, the American Brachytherapy Society (ABS) has a tradition of providing an extensive offering of reports that integrate the best available clinical evidence from systematic research and individual clinical expertise to assist radiation oncologists and patients when making difficult management decisions regarding brachytherapy (BT). In the issues 3 and 4 of volume 12 of Brachytherapy journal, the ABS offered three consensus statements, namely ABS–Groupe Européen de Curiethérapie–European Society of ...
Source: Brachytherapy - September 23, 2013 Category: Cancer & Oncology Authors: Mark K. Buyyounouski, Akila N. Viswanathan, Bradley R. Prestidge, American Brachytherapy Society's Committee for Evidence-Based Brachytherapy and Board of Directors Tags: Editorial Source Type: research
High-dose-rate brachytherapy - a novel treatment approach for primary clear cell adenocarcinoma of male urethra.
Authors: Lewis S, Pal M, Bakshi G, Ghadi YG, Menon S, Murthy V, Mahantshetty U
Abstract
The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surgery, underwent cystoscopic assisted intraluminal HDR brachytherapy. Patient received a dose of 36 Gy in 9 fractions (4 Gy per fraction) followed by a boost of 24 Gy in 6 fractions. At 11 months post treatment, disease is well controlled...
Source: Journal of Contemporary Brachytherapy - November 18, 2015 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma.
CONCLUSIONS: Electronic brachytherapy with Esteya(®) appears to be an effective, simple, safe, and comfortable treatment for nodular and superficial BCC associated with excellent cosmesis. It could be a good choice for elderly patients, patients with contraindications for surgery (due to comorbidities or anticoagulant drugs) or patients where surgery would result in a more disfiguring outcome. A longer follow-up and more studies are needed to confirm these preliminary results.
PMID: 26207112 [PubMed]
Source: Journal of Contemporary Brachytherapy - November 18, 2015 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Patterns of care study of brachytherapy in New South Wales: malignancies of the uterine corpus.
CONCLUSIONS: Brachytherapy patients, techniques, and numbers/unit for uterine corpus malignancies were similar in NSW compared to the USA but more dispersed than in Western Europe. Doses prescribed may not be optimal in lower gynaecological BT caseload departments - the significance of this represents an area in which more research is needed.
PMID: 26207111 [PubMed]
Source: Journal of Contemporary Brachytherapy - November 18, 2015 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
